Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Neurologic complications of vaccinations.
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
JAML mediates monocyte and CD8 T cell migration across the brain endothelium.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.
Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.
The role of antiproliferative gene Tob1 in the immune system.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Impaired social cognition in multiple sclerosis.
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
Longitudinal associations between brain structural changes and fatigue in early MS.
Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.
Pages
« first
‹ previous
…
487
488
489
490
491
492
493
494
495
…
next ›
last »